Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists concerned by MCR-1 spread
At two randomly chosen farms in Portugal, 98 per cent of 100 healthy pigs sampled harboured the resistance gene.
Research discussed at US meeting

International scientists have shared research on the spread of the MCR-1 gene, which confers resistance to last resort antibiotic colistin.

The gene was found in pigs in China around 18 months ago, and since then has been discovered around the world. Although some evidence suggests plasmids carrying the gene have existed for decades, its prevalence appears to be increasing, according to a report in Nature.

Speaking at a meeting of the American Society for Microbiology (ASM) in New Orleans last week, researchers described the results of a recent study in Guangzhou, China. The team analysed gut bacteria in 8,000 human faecal samples collected over five years. MCR-1 was found in 497 samples and the prevalence of the gene rose in that time, according to Guo-Bao Tian from the Sun Yat-sen University.

In addition, 10 per cent of the MCR-1 genes were found in strains of E. coli that were also resistant to other antibiotics.

In another study presented at the meeting by Tian’s team, MCR-1 was found in 25 per cent of patients at a Guangzhou hospital last year. A strain of E. coli found in the samples also contained the gene blaNDM-5, which confers resistance to carbapenems.

A team led by Catherine Logue of Iowa State University reported finding resistance genes to carbapenems and to antibiotics from the class that includes penicillin. They were discovered in swab samples from 107 farmed chickens in Brazil, where the use of colistin for agricultural purposes was banned in 2016. About 60 per cent of the samples had E. coli strains that carried MCR-1.

The prevalence of MCR-1 was found to be even higher than this at two randomly chosen farms in Portugal. Antibiotic researcher Laurent Poirel, of the University of Fribourg in Switzerland, said 98 per cent of 100 healthy pigs sampled harboured the resistance gene. The team also found MCR-1 on three types of plasmid and in multiple strains of bacteria, suggesting the pigs were not necessarily spreading it from one to another, but getting it from various sources.

Logue and Tian found MCR-1 in a number of different plasmids and strains of bacteria. The gene appears to be particularly skilled at jumping from one organism to another, which could allow it to become very successful - and difficult to treat. In theory, if a person ate undercooked meat or worked with animals harbouring bacteria carrying MCR-1, their gut microbes could acquire the resistance gene, researchers said.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.